Christopher N. Vlangos

5.7k total citations · 2 hit papers
24 papers, 2.8k citations indexed

About

Christopher N. Vlangos is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Christopher N. Vlangos has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Genetics and 8 papers in Nephrology. Recurrent topics in Christopher N. Vlangos's work include Genomic variations and chromosomal abnormalities (8 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal and related cancers (6 papers). Christopher N. Vlangos is often cited by papers focused on Genomic variations and chromosomal abnormalities (8 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal and related cancers (6 papers). Christopher N. Vlangos collaborates with scholars based in United States, Germany and United Kingdom. Christopher N. Vlangos's co-authors include Gail E. Herman, David T. Miller, Kent D. McKelvey, Wendy K. Chung, C. Sue Richards, Christa Lese Martin, Teri E. Klein, Sherri J. Bale, Michael S. Watson and Sarah H. Elsea and has published in prestigious journals such as Nature Genetics, PLoS ONE and PEDIATRICS.

In The Last Decade

Christopher N. Vlangos

24 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

2016 1.0k citations Sarah S. Kalia, Sherri J. Bale et al. Genetics in Medicine profile →
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)

2021 302 citations David T. Miller, Kristy Lee et al. Genetics in Medicine profile →

Peers

Christopher N. Vlangos

GENET

NEPHR

PFM

GENET

Sylvie Salenave France

Monique Losekoot Netherlands

Pat Kendall‐Taylor United Kingdom

Wendy Bruening United States

Hatem El‐Shanti United States

Christine M. Eng United States

Tom H. Lindner Germany

Mario Pirastu Italy

Neva E. Haites United Kingdom

Patrice Rodien France

Sylvie Salenave France

Christopher N. Vlangos

542 ×0.4

GENET

665 ×0.6

108 ×0.1

NEPHR

170 ×0.5

PFM

335 ×1.0

GENET

Citations per year, relative to Christopher N. Vlangos Christopher N. Vlangos (= 1×) peers Sylvie Salenave

Countries citing papers authored by Christopher N. Vlangos

Since Specialization

Citations

This map shows the geographic impact of Christopher N. Vlangos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Vlangos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Vlangos more than expected).

Fields of papers citing papers by Christopher N. Vlangos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher N. Vlangos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Vlangos. The network helps show where Christopher N. Vlangos may publish in the future.

Co-authorship network of co-authors of Christopher N. Vlangos

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher N. Vlangos. A scholar is included among the top collaborators of Christopher N. Vlangos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher N. Vlangos. Christopher N. Vlangos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, David T., Kristy Lee, Allan Gordon, et al.. (2021). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 23(8). 1391–1398. 142 indexed citations

Miller, David T., Kristy Lee, Wendy K. Chung, et al.. (2021). ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine. 23(8). 1381–1390. 302 indexed citations breakdown →

Kalia, Sarah S., Sherri J. Bale, Wendy K. Chung, et al.. (2016). Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genetics in Medicine. 19(2). 249–255. 1023 indexed citations breakdown →

Vlangos, Christopher N., Dan R. Robinson, Arul M. Chinnaiyan, et al.. (2013). Next-Generation Sequencing Identifies the Danforth's Short Tail Mouse Mutation as a Retrotransposon Insertion Affecting Ptf1a Expression. PLoS Genetics. 9(2). e1003205–e1003205. 15 indexed citations

Vlangos, Christopher N., Todd Ackley, Hans van Bokhoven, et al.. (2010). Comprehensive genetic analysis of OEIS complex reveals no evidence for a recurrent microdeletion or duplication. American Journal of Medical Genetics Part A. 155(1). 38–49. 21 indexed citations

Schoeb, Dominik S., Gil Chernin, Saskia F. Heeringa, et al.. (2010). Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrology Dialysis Transplantation. 25(9). 2970–2976. 57 indexed citations

Heeringa, Saskia F., Clemens Möller, Jianyang Du, et al.. (2009). A Novel TRPC6 Mutation That Causes Childhood FSGS. PLoS ONE. 4(11). e7771–e7771. 125 indexed citations

Vlangos, Christopher N., et al.. (2009). Caudal regression in adrenocortical dysplasia (acd) mice is caused by telomere dysfunction with subsequent p53-dependent apoptosis. Developmental Biology. 334(2). 418–428. 20 indexed citations

Truong, Hoa T., Santhosh Girirajan, Stephen R. Williams, et al.. (2008). Diagnosing Smith–Magenis Syndrome and Duplication 17p11.2 Syndrome by RAI1 Gene Copy Number Variation Using Quantitative Real-Time PCR. Genetic Testing. 12(1). 67–73. 9 indexed citations

10.

Chernin, Gil, Saskia F. Heeringa, Rasheed Gbadegesin, et al.. (2008). Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome. Pediatric Nephrology. 23(9). 1455–1460. 36 indexed citations

11.

Girirajan, Santhosh, Paula M. Hauck, Stephen R. Williams, et al.. (2008). Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response. Mammalian Genome. 19(4). 246–262. 18 indexed citations

12.

Hinkes, Bernward, Christopher N. Vlangos, Saskia F. Heeringa, et al.. (2008). Specific Podocin Mutations Correlate with Age of Onset in Steroid-Resistant Nephrotic Syndrome. Journal of the American Society of Nephrology. 19(2). 365–371. 84 indexed citations

13.

Heeringa, Saskia F., Christopher N. Vlangos, Gil Chernin, et al.. (2008). Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrology Dialysis Transplantation. 23(11). 3527–3533. 56 indexed citations

14.

Gbadegesin, Rasheed, Bernward Hinkes, Christopher N. Vlangos, et al.. (2007). Mutational analysis of NPHS2 and WT1 in frequently relapsing and steroid-dependent nephrotic syndrome. Pediatric Nephrology. 22(4). 509–513. 33 indexed citations

15.

Girirajan, Santhosh, Roberto Mendoza‐Londono, Christopher N. Vlangos, et al.. (2007). Smith–Magenis syndrome and moyamoya disease in a patient with del(17)(p11.2p13.1). American Journal of Medical Genetics Part A. 143A(9). 999–1008. 12 indexed citations

16.

Girirajan, Santhosh, Christopher N. Vlangos, Barbara Szomju, et al.. (2006). Genotype–phenotype correlation in Smith-Magenis syndrome: Evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genetics in Medicine. 8(7). 417–427. 108 indexed citations

17.

Vlangos, Christopher N., Meredith Wilson, Jan Blancato, Ann C. M. Smith, & Sarah H. Elsea. (2004). Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith–Magenis syndrome should contain the RAI1 gene. American Journal of Medical Genetics Part A. 132A(3). 278–282. 30 indexed citations

18.

Vlangos, Christopher N.. (2003). Refinement of the Smith–Magenis syndrome critical region to ∼950kb and assessment of 17p11.2 deletions. Are all deletions created equally?. Molecular Genetics and Metabolism. 79(2). 134–141. 71 indexed citations

19.

Vlangos, Christopher N., et al.. (2001). Genomic organisation of the ∼1.5 Mb Smith-Magenis syndrome critical interval: Transcription map, genomic contig, and candidate gene analysis. European Journal of Human Genetics. 9(12). 892–902. 25 indexed citations

20.

Vlangos, Christopher N., Parimal Das, Pragna I. Patel, & Sarah H. Elsea. (2000). Assignment<footref rid="foot01"><sup>1</sup></footref> of developmentally regulated GTP-binding protein (DRG2) to human chromosome band 17p11.2 with somatic cell hybrids and localization to the Smith-Magenis syndrome critical interval. Cytogenetic and Genome Research. 88(3-4). 283–285. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact